Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $55.9671 (6.43%) ($54.2540 - $56.6912) on Mon. Nov. 2, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.79% (three month average) | RSI | 67 | Latest Price | $55.9671(6.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 4.3% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(48%) IBB(47%) IVE(46%) SPY(46%) | Factors Impacting ABBV price | ABBV will decline at least -1.395% in a week (0% probabilities). VIXM(-21%) TLT(-14%) UUP(-9%) IGOV(-3%) GLD(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.395% (StdDev 2.79%) | Hourly BBV | 0 () | Intraday Trend | 2.9% | | | |
|
5 Day Moving Average | $49.96(12.02%) | 10 Day Moving Average | $48.01(16.57%) | 20 Day Moving Average | $48.33(15.8%) | To recent high | -9% | To recent low | 31.3% | Market Cap | $98.742b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |